Telegraft Hub Home

Welcome to the ISCT Telegraft Hub

The cure of Emily Whitehead’s leukemia with her own gene engineered lymphocytes in 2012[i] will certainly be recognized by posterity as the watershed moment that launched the modern era of cancer cell immunotherapy – and this rising tide of inarguable success is lifting all the boats in the Cell and Gene Therapy (CGT) space. 

Remaining open-minded and maintaining objectivity are goals to which I strive in both my personal and professional life.  During a heated political discussions at a family gathering or while reviewing a manuscript for publication, preconceptions, predispositions and adherence to dogma should all be avoided.  But here, I come clean and share my affinity and bias as an ISCT Telegraft Editor and as co-leader of the AABB-ISCT Joint Working Group .  Read More


ISCT Calendar


Upcoming Events

ISCT 2023 Annual Meeting